Literature DB >> 6290811

Caffeine stimulates beta-endorphin release in blood but not in cerebrospinal fluid.

M A Arnold, D B Carr, D M Togasaki, M C Pian, J B Martin.   

Abstract

Plasma beta-endorphin and prolactin profiles were obtained from groups of unstressed, adult male rats. The infusion of caffeine (20 mg/kg) via a chronic, indwelling intra-atrial cannula results in a prompt and sustained (2-2.5 h) rise In plasma beta-endorphin levels. The infusion of the opiate antagonist naloxone causes a modest (40%) decrease in plasma beta-endorphin and blunts the elevation in plasma beta-endorphin following caffeine administration. In contrast, plasma prolactin levels were unchanged following caffeine administration and were decreased by treatment with naloxone. Caffeine treatment did not effect CSF beta-endorphin levels or the release of beta-endorphin from hemipituitaries incubated in vitro.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6290811     DOI: 10.1016/0024-3205(82)90174-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  The influence of naloxone on the circulatory effects of captopril.

Authors:  P C Rubin; J A Millar; S Sturani; C Lawrie; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

2.  Potentiation of morphine analgesia by caffeine.

Authors:  A L Misra; R B Pontani; N L Vadlamani
Journal:  Br J Pharmacol       Date:  1985-04       Impact factor: 8.739

3.  No effect of caffeine on exercise performance in high ambient temperature.

Authors:  Bart Roelands; Luk Buyse; Frank Pauwels; Frans Delbeke; Koen Deventer; Romain Meeusen
Journal:  Eur J Appl Physiol       Date:  2011-04-02       Impact factor: 3.078

Review 4.  Selected health and behavioral effects related to the use of caffeine.

Authors:  R J Lamarine
Journal:  J Community Health       Date:  1994-12

5.  Caffeine as an opioid analgesic adjuvant in fibromyalgia.

Authors:  J Ryan Scott; Afton L Hassett; Chad M Brummett; Richard E Harris; Daniel J Clauw; Steven E Harte
Journal:  J Pain Res       Date:  2017-07-28       Impact factor: 3.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.